Haematopoietic and Lymphoid Malignancies and Immune System Development

Haematopoietic and lymphoid malignancies are tumors that affect the blood, bone marrow, lymph, and lymphatic system. Malignancies of the hematopoietic and lymphoid tissues include the leukemias, myeloproliferative neoplasms, plasma cell dyscrasias and dendritic cell neoplasms.

Immune system

The immune system plays a dual role against cancer: it prevents tumor cell outgrowth and also sculpts the immunogenicity of the tumor cells. Cancer cells are able to escape from the immune system by inhibiting T lymphocytes activation. New immunotherapies have been developed to target these T lymphocytes activation modulators: the immune checkpoints, defined as molecules of immune system that either turn up a signal or turn down a signal. Most of the cancers protect themselves from immune system by inhibiting activation of T cell.

  • Immune modulators
  • Lymphoid Tumors
  • Lymphoid Neoplasms
  • Acute Myeloid Leukaemias
  • Histiocytic Tumors
  • Thymoma
  • Lymphocytic Leukemia
  • Multiple Myeloma

Related Conference of Haematopoietic and Lymphoid Malignancies and Immune System Development

November 28-29, 2024

38th International Conference on Immunology

Aix-en-Provence, France
December 12-13, 2024

5th International Conference on Immunology And Immunotherapy

Zurich, Switzerland
June 16-17, 2025

19th International Conference on European Immunology

Frankfurt, Germany

Haematopoietic and Lymphoid Malignancies and Immune System Development Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in